Edgestream Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.45M | Buy |
|
|||||
|
2025
Q1 | $1.43M | Sell |
|
|||||
|
2024
Q4 | $6.28M | Buy |
|
|||||
|
2024
Q3 | $365K | Sell |
|
|||||
|
2024
Q2 | $5.48M | Sell |
|
|||||
|
2024
Q1 | $7.35M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.07M | Buy |
|
|||||
|
2023
Q2 | $604K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $213K | Sell |
|
|||||
|
2022
Q3 | $4.58M | Buy |
|
|||||
|
2022
Q2 | $2.65M | Buy |
|
|||||
|
2022
Q1 | $2.57M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $961K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $2.67M | Buy |
|